Robert Yoder
Corporate Officer/Principal at TREVENA, INC.
Net worth: 64 981 $ as of 2024-04-29
Robert Yoder active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 2018-12-09 | - |
| Sales & Marketing | 2018-06-10 | 2018-12-09 |
Career history of Robert Yoder
Former positions of Robert Yoder
| Companies | Position | Start | End |
|---|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2015-02-28 | 2018-05-31 |
Training of Robert Yoder
| Dickinson College | Undergraduate Degree |
| Emory University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Yoder
- Experience
